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Abstract pl9 is a 165 amino acid protein that belongs to 
the INK4 family of CDK4 and CDK6 inhibitors. Assignments of 
1H, 15N and 13C resonances have enabled the determination of 
the secondary structure of the protein which is largely a-helical 
(residues 14-18,21-29,54-62,77-83, 87-95,110-116,120-128, 
142-148 and 152-160). The protein comprises five 32-amino acid 
ankyrin-like repeats; each ankyrin repeat contains a helix-ß-
turn-helix core. The exception is the second ankyrin repeat, 
which lacks the first helix. AU ß-turns have a central glycine 
residue flanked by two residues in ß-conformations. There is also 
a high conservation of Ala at position 8 in the first helix and Leu-
Leu(Val) at positions 17-18 of the second helix in all ankyrin 
repeats of pl9. The location of the helix-turn-helix segments 
found in p 19 should be general for all other members of the INK4 
family, including, for example, a homologous tumor suppressor 
pl6itfK4a iH-
i rN heteronuclear steady-state NOE measure-
ments on pl9 indicate that most of the backbone of pl9INK4d 
exists in a well defined structure of limited conformational 
flexibility on the nano- to picosecond time scale. 
Key words: p i9; CDK inhibitor; Ankyrin repeat; INK4; 
Nuclear magnetic resonance 
1. Introduction 
The INK4 proteins constitute a family of cyclin-dependent 
kinase inhibitors that was discovered with the human gene 
product pl6 INKa 3 years ago [1-3]. These proteins interact 
exclusively with the Gl cyclin D-dependent kinases CDK4 
and CDK6, which phosphorylate the retinoblastoma (pRb) 
protein thereby enabling the cell to enter S phase [2-4\. 
INK4 proteins thus can limit this phosphorylation of pRb; 
their ectopic overexpression in proliferating cells can inhibit 
CDKs in vivo [5,6], induce Gl arrest [2,5-10], and revert cell 
transformation in normal diploid fibroblasts by ras and c-myc, 
but not by ras and adenovirus El A [11]. In mammalian cells, 
there exists at least one other family of CDK inhibitors, rep-
resented by prototype CDK inhibitor p21 [2]. In contrast to 
pl6, the p21W a f l /C I P 1 family of proteins can interact with and 
inhibit the activity of a wide spectrum of CDK kinases. 
The INK4 family of CDK inhibitors currently contains four 
gene products: pl6 (also known as INK4a, MTS1, CDK4I, 
and CDKN2 [1,12,13]), pl5 (also known as MTS2, INK4b, 
and pl4 [7,12,14]), pl8 (INK4c [6,7]), and pl9 (INK4d 
[15,16]). Tandemly linked INK4a and INK4b genes map to 
the short arm of human chromosome 9 and their protein 
products function as tumor suppressors [2,3,12,13,17-19]. By 
contrast, INK4 genes encoding pi8 and pi9 map to other 
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human chromosomes lp32 and 19pl3, respectively [6,7,15-
17]. Similar to other INK4 proteins, pl9 INK4d is expressed 
ubiquitously in proliferating cultured cells and in normal 
mouse tissues [6,7,15,17]. These proteins, however, have not 
been linked to tumor formation, evidence against strict redun-
dancy of the INK4 proteins despite their apparently indistin-
guishable biochemical properties [2]. 
All members of the INK4 protein family contain several 32-
amino acid ankyrin-like motifs which are considered to partic-
ipate in protein-protein interactions [20]. The proteins are 
homologous to each other, with pi6 and pi5 having 44% 
identity in the first 50 amino acids and 97% identity in the 
last three ankyrin domains [1,14]. Mouse pl9 and pl8 exhibit 
only 40% amino acid identity to one another, and both show 
a similar degree of homology to human pl6 and pl5 [6]. In 
contrast, mouse pl9 and pi8 exhibit more than 90% amino 
acid identity with their human counterparts [6,15]. The human 
pi9, the subject of our study, has a 48% identity with that of 
human pl6 over a stretch of 130 amino acids [15,16]. There is 
no structural information yet available on any protein of this 
family. In the present report, we describe the determination of 
the complete secondary structure of human pi9 in solution 
using NMR spectroscopy. 1H-15N heteronuclear steady-state 
NOE experiments were performed to further characterize pl9 
protein structure and stability. 
2. Materials and methods 
2.1. Preparation of pl9 
pl9 was expressed and purified in BL21(DE3) (Novagen, Madison, 
WI, USA) as a glutathione fusion protein, using pGEX 2T (Pharma-
cia Biotech, Sweden) as an expression vector as described in [21]. To 
obtain higher expression yields of pl9 in Escherichia coli in minimal 
media, the pl9 gene was subcloned into the Ndel and BamHl restric-
tion sites of the pET15b vector (Novagen) in a frame to a His tag. 
PCR was used to introduce the restriction sites using following pri-
mers: 5'pl9 GGGAATTCCATATG.CTGCTGGAGGAGGTTC; 
3'pl9 GCGGGATCCJTCACAGCGGGGCCACCAT (overhangs 
separated by the underscore). Conditions for the template were as 
follows: pGEX 2T-pl9-pl; polymerase Vent (National Biolabs, 
UK), 2 mM MgS04; 92°C 60 s, 59°C 60 s, 72°C 45 s, 32 cycles. To 
verify the correctness of PCR, this construct was transformed into the 
E. coli strain JM83 [22] to produce a plasmid used for sequencing. 
For expression, the construct was transformed into E. coli strain 
BL21(DE3)pLys (Novagen). Overnight cultures of BL21(DE3)pLys-
pl9 were diluted 20-fold with a fresh medium (see below). Recombi-
nant proteins were induced with 1 mM IPTG (isopropyl-ß-D-thioga-
lactopyranoside) at an OD of 0.9 for 2 h in full (LB) and selective 
media, 3 h in minimal media, and 5 h in the D20-medium. 
2.2. lhN, 13C, and 2H labeling 
A standard LB medium was used for full media. The expression 
level of pl9 was about 8 mg/1. The uniform 15N-labeled and 13C/15N-
double labeled samples were prepared by growing bacteria on a M9 
minimal medium containing 15N-ammonium chloride (1 g/1) as the 
only nitrogen source [23,24] or 15N-ammonium chloride (1 g/1) and 
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13C-glucose (2 g/1) in case of double-labeled samples, supplemented 
with minerals and cofactors [25]. The same media was used for 15N/ 
3C/2D labeling, except that a 70% D2O/30% H 2 0 mixture was used. 
The bacteria were first grown in full media to an OD of 1.0 and then 
diluted 1:10 to minimal medium (30% D2O) and grown to an OD of 
1.0 in order to adapt the bacteria to D 2 0 conditions. This solution 
was diluted 1:5 to the 70% D 2 0 minimal medium and grown to an 
OD of 0.5 and used to inoculate a 90% D 2 0 minimal overnight 
culture. The expression was then performed as described above for 
a 70%) D 2 0 minimal medium culture. The yield of the purified protein 
was about 7 mg/1 culture. Reverse labeling was performed in the 15N 
minimal medium enriched with one 14N-amino acid. The following 
reverse labeled samples were prepared using 14N histidine (200 mg/ 
1), 14N asparagine (200 mg/1), 14N threonine (800 mg/1), 14N lysine 
(200 mg/1), 14N methionine (200 mg/1), 14N arginine (400 mg/1), and 
14N phenylalanine (1 g/1). For 15N amino acid selective labeling, the 
minimal medium (14N) was enriched with unlabeled amino acids and 
the double amount of the 15N labeled amino acid [24]. Selectively 
labeled pl9 in 15N glycine/serine, leucine, valine, alanine and phenyl-
alanine were prepared. The yield of purified protein was about 15 mg/ 
1. Purification of the protein was performed under either native or 
denaturing conditions. In the native conditions, the cell pellet from 
a 1-1 culture was resuspended in 20 ml buffer A (5 mM imidazole, 50 
mM natrium phosphate, pH 8.0) and lysed using a French press. The 
cell solution was centrifuged at 60000Xg and 4°C for 30 min. The 
supernatant was loaded on a 3 ml Ni-NTA column (Qiagen, Hilden, 
Germany) washed with 50 ml buffer A, 100 ml buffer B (20 mM 
imidazole, 50 mM natrium phosphate, pH 8.0) and eluted using a 
100 ml gradient comprising buffer A and buffer C (200 mM imidazole, 
50 mM Na-phosphate, pH 8.0). Fractions were analyzed by SDS-
PAGE and pure fractions were concentrated with Centricon 10 and 
dialyzed against the sample buffer S (50 mM NaCl, 50 mM KC1, 20 
mM phosphate, pH 6.9). Under denaturing conditions, the cell pellet 
from a 1-1 culture was resuspended in 20 ml buffer D (8 M urea, 100 
mM phosphate, 10 mM Tris, pH 8.0) and stirred for 1 h to lyse cells. 
This solution was centrifuged at 20°C and 80000Xg for 1 h and 
loaded on a 5 ml Ni-NTA column and washed with 50 ml buffer D 
and 50 ml buffer E (buffer D at pH 6.5). P19 was refolded on the 
column applying a 100 ml gradient of buffer D and refolding buffer R 
(5 mM imidazole, 400 mM NaCl, 10 mM Tris, 100 mM phosphate, 
20% glycerol) within 2 h. The column was washed again using 100 ml 
buffer B. The pure protein was eluted using buffer C, concentrated 
and dialyzed against buffer S. Optionally, the His-tag was removed to 
simplify some NMR spectra. In this case, the protein solution was 
dialyzed against buffer T (50 mM Tris-HCl, pH 7.4, 2.5 mM CaCl2, 
100 mM KC1) and 5 units of thrombin per mg protein was added and 
incubated for 24 h at 8°C. The removal of His-tag was complete. 
After digestion, the solution was dialyzed against buffer S. Thrombin 
was from human plasma and highly purified (T3010, Sigma, Deisen-
hofen, Germany). 
2.3. Conditions for NMR samples 
Samples for NMR typically contained 0.5-0.8 mM protein dis-
solved in buffer S (see above), 90% H2O/10% D 2 0 at pH 6.9. Several 
sample conditions were tested to optimize for line width and solubility 
and to prevent aggregation. A pH titration was performed by adding 
minute amounts of 1 N HC1 or 1 N NaOH. At four different pH 
values (6.5, 6.9, 7.5 and 8.4) each time a 1-D spectrum was recorded 
to estimate the line width and a HSQC spectrum (see NMR spectro-
scopy below) was recorded to check the resonances for chemical shift 
behavior. The optimal recording temperature was determined by in-
creasing the temperature from 17°C to 32°C in 2°C intervals. The line 
width should be narrowed at higher temperatures, but this beneficial 
effect was offset by a strong tendency to aggregate at higher tempera-
tures. Because of the finding that pl9 is prone to aggregation, 1-D 
spectra were recorded in the presence of CHAPS [26] (Sigma) and 
CaCl2 (30 mM and 60 mM). There were no dramatic changes in 
the case of CHAPS and almost complete precipitation of the protein 
upon adding CaCl2. Also, a stepwise dilution was performed to de-
termine the optimal protein concentration. A 2 mM unlabeled protein 
sample was diluted 1:2 with buffer S directly in the NMR tube and a 
1-D spectrum was recorded after removal of half of the sample vol-
ume. This was again diluted 1:2 with buffer S and so on. The same 
procedure was carried out on a 15N/13C/2H-triple labeled sample. This 
results in the observation that pi9 aggregation is strongly dependent 
on the protein concentration and therefore only concentrations below 
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1 mM are suitable for NMR; the optimal concentration of the protein 
was determined to be 0.5-0.7 mM. Slowly exchanging amide protons 
were identified by recording a series of 4H-15N HSQC spectra at 5°C 
recorded directly after addition of D 2 0 and after 1, 2, 4, 6, 12 and 24 
h. The measurement time for the first two spectra was 30 min. 
2.4. NMR spectroscopy 
NMR experiments were carried out at 27°C on the Bruker DRX 
600 and DMX 750 spectrometers. Both spectrometers were equipped 
with triple resonance probeheads and PFG accessories. The two-di-
mensional total correlation spectroscopy (TOCSY) was performed 
with the MLEV-17 sequence [27] for isotropic mixing and a spin-
lock period of 25 ms. The TOCSY pulse sequence included presatura-
tion of the water resonance for measurements in H 2 0 [28]. 2-D 
NOESY experiments [29] were recorded with a pulse sequence in 
which the last 90° pulse was replaced by a jump-return sequence to 
suppress the water resonance [28]. A gradient pulse of 1 ms at the end 
of the mixing time of 120 ms was also used. 2048 complex data points 
were acquired in the time domain t2 with a spectral width of 15 ppm 
(F2). 750 increments in ti with a Fi spectral width of 9.7 ppm and 256 
scans per ti value were added. 2-D Ή - 1 5 Ν HSQC correlation spectra 
were recorded using the method of Mori et al. [30] to avoid signal 
losses due to fast chemical exchange. For all 4H-15N correlations, 128 
ti increments were acquired with a sweep width of 2100 Hz in the 
nitrogen dimension. The 3D Ή - 1 5 Ν NOESY-HSQC spectrum was 
recorded in a water-flip-back version using constructive radiation 
damping [31] with a mixing time of 90 ms, and with 16 scans per 
ti-t2 pair. The spectral width and number of points acquired were 
11.3 ppm and 360 real points in 'HiFi), 20.6 ppm and 44 complex 
points in 15N(F2), and 14 ppm and 1024 complex points in
 4H(F3) 
with the 4Η(Ρι), 15N(F2) and
 4HN(F3) carrier frequencies placed at 
4.73 ppm, 117.14 ppm and 4.73 ppm, respectively. Sequential assign-
ment was performed with triple-resonance experiments using the 15N/ 
3C/2D-labeled pl9. Modified versions of the CT-HNCA and CT-
HNCO experiments [32] were acquired, using the WATERGATE 
sequence [33]. The differentiation between intra- and interresidual 
contacts in the HNCA was achieved with a HN(CO)CA [32], A mod-
ified version of the HN(CA)CO [34] together with the HNCO [32] was 
used to confirm the assignment and to resolve ambiguities. In all triple 
resonance experiments deuterium decoupling was employed to remove 
the strong quadrupolar C-D coupling [35-38]. The lock was disabled 
during the 2D-decoupling. For the 3-D 15N separated HN-H a correla-
tion spectrum HNHA, which yielded the 3J(HN-Ha) coupling con-
stants from the ratio of the HN-H° cross peak to the HN-HN diagonal 
peak intensity [39], the spectral width in the 'H(F2) dimension was 
9.00 ppm and 80 complex points were acquired. The 4H-15N hetero-
nuclear NOE measurements were carried out using the pulse sequence 
of [40] on a 15N uniformly labeled sample. Saturation of the amide 
protons in the heteronuclear NOE experiment was achieved by the 
application of a series of 120° pulses prior to the experiment [40]. 
Intensities of the cross peaks were obtained from the peak heights 
of two independent sets of the NOE spectra. The accuracy of the 
NOE measurements was ±7%> for well resolved peaks and ±10-
20%) for overlapped peaks. All 3-D spectra were processed and eval-
uated on SGI workstations with the software CC-NMR [41]. A single 
zero filling with extensive linear prediction methods in all indirectly 
detected dimensions was performed for the triple resonance experi-
ments. 
3. Results and discussion 
3.1. Biophysical properties of pl9 
The pi9 protein used in this study consists of residues Leu-
l-Leu-165 of the human pl9 sequence plus an initial methio-
nine residue, and in the most cases an N-terminus His-tag 
sequence of 19 residues. pl9 was a difficult protein to study 
by NMR because of its low solubility in water, aggregation, 
and a narrow dispersion of the 1HN chemical shifts (Fig. 1). 
The XH, 15N and 13C spectra of pl9 exhibited line widths 
broader than those expected for a protein of 19 kDa at con-
centrations of 0.2-1 mM. Solubility of the protein was low in 
general, better at higher pH (pH 7.5, 1 mM) and decreasing 
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Fig. 1. 1H-16N HSQC spectrum of uniformly 15N labeled human pi9INK4d recorded at pH 6.9, 27°C. Residue specific assignments of the back-
bone :Η and 15N frequencies are indicated. The horizontal lines connect the side-chain NH2 frequencies of asparagine and glutamine residues. 
Cross peaks of minor conformation are marked with primes. 
drastically below pH 6.5. Unfortunately, aggregation of the 
protein increased at higher pH (and higher concentrations). 
Various conditions, including changes in concentrations and 
pH, adding detergents, and salts were tried to reduce aggrega-
tion (see Section 2). Only lowering the concentration of the 
protein was found to be effective in reducing the extent of 
aggregation. The optimal NMR conditions for pl9 were chos-
en as follows: pH 6.9, the protein concentration 0.7 mM in 
50 mM NaCl/50 mM KC1/20 mM sodium phosphate. Under 
these conditions, the HNCA triple resonance experiment [42] 
yielded 30 correlations. Ή - ^ Ν TOCSY-HSQC [43] and 1H-
13C HCCH-TOCSY [44] spectra gave even fewer transfers. 
Acceptable triple-resonance spectra could only be obtained 
after 70% deuteration of the protein. Thus, sequence specific 
assignments were carried out with triple-resonance spectra on 
the 15N/3C/2H-labeled protein [35-38] and sequential NOEs 
were extracted from the 3D Ή - ^ Ν NOESY-HSQC [31] spec-
trum recorded on the 15N-labeled pl9. The assignment fre-
quently turned out to be ambiguous. Crucially helpful were 
HSQC spectra of 15N selectively amino acid [24] labeled pl9 
and 14N reverse amino acid labeled samples, the latter ob-
tained from the 15N minimal media supplemented with one 
or two unlabeled amino acid. Spin systems were identified 
mostly by residue specific labeling. A complete list of assign-
ments is available from the authors. Approximately 95% of 
the 15N, 13C and XH backbone and 60% of the *Η side-chain 
resonances have been assigned. 
3.2. Conformational stability of pl9 
In general NOESY spectra of pi9 exhibited a relatively 
small number of long-range NOEs for the protein of its size 
and several residues even showed no sequential NOEs at all. 
For example, no sequential, medium- or long-range NOEs 
were observed for residues Arg-25-His-29, Ala-45-Leu-46, 
and Ile-111. The Arg-25-His-29 residues could still be identi-
fied as cc-helical as they exhibited significantly downfield-
shifted 1 3C a , which is typical of a helical structure; also, vic-
inal coupling constants (3JNH,HOI) were consistent with those in 
an oc-helix (Fig. 2). 
In order to check whether this paucity of the NOE data 
could be ascribed to the protein flexibility, a 2-D ΧΗ-15Ν 
heteronuclear NOE experiment [40,45] was carried out on 
the 15N-labeled pi9. The experimental 15N NOE values are 
plotted against amino acid sequence in Fig. 3. Quantitative 
NOE measurements were possible for 147 residues, with an 
average value of 0.83. The heteronuclear 15N NOE data of 
pl9 indicated that most of the protein backbone existed in a 
structure of limited conformational flexibility on a picosecond 
time scale, with any motions faster than the rate of overall 
tumbling (in nanoseconds) of small magnitude [46-48]. The 
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Fig. 2. Summary of the short-range (i—j < 5) NOEs, 3J(HN-Ha) coupling, and variation of 13Ca chemical shifts from random coil values for 
pl9INK4d. The NOEs, classified as weak, medium, or strong, are represented by the heights of the bars. NOEs that were uncertain because of 
spectral overlap are indicated by gray bars. Residues 81, 82, 93, 94, 95, 102, 109, 113, 114, 115, 124, 126, 127, and 159 showed slowly exchang-
ing amide hydrogens that did not completely exchange for 2H after 2 h at 5°C. For 3J(HN-Ha) coupling constants, small couplings (< 5 Hz) 
are marked with filled squares and large couplings (> 7 Hz) are represented with open squares. Boxed regions (gray shaded) represent oc-hel-
ices. The amino acid sequence of pl9 is divided into the five ankyrin repeats which were aligned with each other to match sequence and struc-
turally equivalent residues. Residues 1-6 are not shown as they do not belong to the ankyrin repeat domains and were disordered in solution. 
exceptions were C-terminal residues 164-166, which exhibited 
NOEs close to zero or negative thereby indicating significant 
rapid motion in this fragment of the protein backbone. Com-
bined with the 3JNH-HOI coupling constants of 7 Hz [49], these 
data indicate that these residues formed a random conforma-
tion. No NOE data could be extracted for residues 1-3 and 8-
11. However, residues 1-6 are also expected to be in the ran-
dom conformation; they are close to an unstructured His-tag 
and include flexible residues 4 and 6 with small NOE values. 
In addition, residues Ala-164 and Leu-166, flanking Pro-165, 
showed the presence of minor and major conformations in 
ratio 1:4.5, respectively, slowly exchanging with each other. 
There were also a few residues in pl9 that displayed 15N NOE 
values characteristic of increased flexibility (15N NOEs more 
than 25% smaller than the average value which has an error of 
± 7%) [46-48]. These residues were 68, 69 and 129. All these 
residues were located at the ends of ankyrin repeats. Exclud-
ing trivial cases of the N- and C-terminal residues discussed 
above, there was however no evident correlation between res-
idues that showed the presence of this increased flexibility and 
lack of proton-proton NOEs. Most probably therefore, the 
residues that lack proton-proton NOEs are on the solvent 
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exposed surface of the protein too far away from the main 
body of the molecule to give rise to NOE contacts. 
3.3. Secondary structure and topology of ankyrin-like repeats 
An overview of the observed medium-range backbone 
NOEs is shown in Fig. 2. These NOEs, mostly identified 
from the 3-D 15N-resolved ^H/HJ-NOESY-HSQC spectra, 
are the basis for the determination of the secondary structure 
elements in proteins [49]. Short distances characteristic for oc-
helices, comprising HN(i)-HN(i+l), HN(i)-HN(i+2), Ha(i)-
HN(i+3) and Ha(i)-HN(i+4) were found in the NOESY spec-
tra. Additionally, chemical shifts of backbone atoms (13Ca, 
13C° and 1Ha) were used to predict secondary structures pres-
ent in the protein sequence [50,51]. It can be seen from Fig. 2 
that pi9 is a highly a-helical protein with a striking topology 
which consists of five almost equally spaced helix-turn-helix 
segments between residues 14-30, 54-62, 77-95, 110-128, and 
142-160. With the exception of the second segment (residues 
54-62), each segment is 16-19 residues long and has a short 
turn located between residues 5-7 and 8-11. The results of an 
H/D amide exchange experiment also corroborated with the 
observed secondary structure elements. Slowly exchanging 
amide protons were observed for residues 81, 82, 93, 94, 95, 
113, 114, 115, 124, 126, 127 and 159, all of them located at the 
C-terminal parts of the helices; additionally residues 102 and 
109 were also in slow exchange. The pattern of NOEs, chem-
ical shifts of backbone atoms 1 3Ca and 1 H a , and large 
3JNH,HCI coupling constants indicated that the turns occupied 
the ß-region of φ-ψ space. The helix-turn-helix structures, 
which are displaced slightly toward the N-terminus from the 
center of an ankyrin repeat, constitute the core of ankyrin 
repeats [20]. It is worth stressing that the present NMR 
data unequivocally showed absence of the first helix in the 
second ankyrin repeat. Involvement of this segment in the 
formation of a hydrophobic core of the protein could be 
one possible explanation for its unusual feature. The presence 
of several long-range NOE contacts, mainly linking the ring 
protons of Phe-86 to Phe-51 and Phe-125, and linking the ring 
protons of Phe-86 to the H a protons of Gly-52, indicated the 
existence of a hydrophobic patch in this region. 
All ß-turns in the helix-turn-helix segments have a central 
glycine residue flanked by two residues in ß-conformations. 
Fig. 3. Plot of the 15N heteronuclear NOE as a function of the resi-
due number for pl9INK4d at 27°C. Residues for which no results are 
shown correspond either to proline residues or to residues for which 
the relaxation data could not be extracted. Stippled gray bars mark 
residues which were overlapped (see text). 
Fig. 4. Structural and sequence alignment of pl9INK4d and pl6INK4a. 
The structurally equivalent residues are marked in gray. Boxed re-
gions (gray shaded) represent a-helices. 
Thus, our experimental data confirm nicely the prediction of 
the secondary structure of ankyrin repeats [20,52], which in-
dicated that a typical ankyrin repeat should have an eight 
residue long hydrophobic oc-helix, starting at residue 16, pre-
ceded by a Gly containing ß-turn. Based on the structural and 
sequence alignment of ankyrin repeats in pl9 (Figs. 2 and 4), 
it can be seen that there is also a high conservation of some 
residues in the ankyrin helices. Ala at position 8 in the first 
helix and Leu-Leu(Val) at positions 17-18 of the second helix 
are highly conserved among all ankyrin repeats of pi9. We 
predict also that the location of the helix-turn-helix structures 
found in pi9 should be general for other members of the 
INK4 family. An example of such a prediction is provided 
in Fig. 4 with a structural and sequence alignment of pl9 INK4d 
and pl6 INK4a . 
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